03 // the amount and the timing
What do Sermorelin study amounts tell you?
Sermorelin is an injected medicine that prompts more growth-hormone release. You'll see why the amounts and timing differed, and why research can't choose your treatment.
Which question was each Sermorelin dosage study asking?
Children's growth and older people's hormone levels were different research questions. A test of the gland asked another question again. The amounts used can't decide treatment for your symptoms and age. Some pharmacies mix a prescription medicine instead of supplying a factory-made brand. Those mixed medicines come under separate rules. Ask your pharmacist and doctor what that means for the product being discussed.
Research doesn't choose your prescription.
Thorner enrolled 110 children before puberty with low growth-hormone levels. Their bedtime skin shots contained 30 micrograms for each kilogram of weight [3]. A kilogram counts body weight in amounts just over two pounds. Micrograms measure tiny weights, each weighing a gram divided into a million parts. The separate gland test used a single vein shot containing 1 microgram per kilogram [6]. Khorram studied nineteen adults aged 55-71 over 16 weeks. Their nightly skin shots contained 10 micrograms per kilogram [9]. Other older-adult studies used fixed nightly amounts of 0.2-0.5 milligrams, small fractions of a gram. Those were study choices for the people enrolled.
Why isn't a Sermorelin research amount your own treatment amount?
The children's bedtime skin shots contained 30 micrograms for each kilogram of weight [3]. Vittone's older men received nightly shots too [10]. Khorram's women and men had 10 micrograms per kilogram nightly over 16 weeks [9]. I'd ask why those findings fit the problem you've brought to the visit. You can bring questions about the tests needed, how much each visit would cost and when the doctor would review care, so you're clear about the time and expense before deciding.
Why can growth hormone stay high after Sermorelin leaves blood?
Frohman's adults received shots in a vein or just beneath skin. The amount of Sermorelin in their blood halved after about 11-12 minutes [5]. After skin shots, blood levels reached their highest point around 5-20 minutes. The kidneys remove the drug, and the drug breaks into smaller parts. Those blood measurements don't tell you when extra growth-hormone release ends.
Measuring drug in blood isn't the same as measuring the gland's hormone release.
Ishida's review describes growth-hormone release remaining higher for 2-4 hours after a skin shot. About an hour after the shot, little Sermorelin remained in blood [12]. The gland had already begun making and sending out more growth hormone. Continued release doesn't mean Sermorelin is still moving through the blood. Studies of tesamorelin and other related drugs describe changes that slow their breakdown [13][16]. Staying in blood longer doesn't prove a greater health benefit.
What does Sermorelin's half-life mean for these times?
Half-life means the time for the amount of drug in blood to halve. Studies found about 10-20 minutes, while extra growth-hormone release lasted longer [5][12]. The drug's 12-minute half-life could go with a 2-4-hour period of extra growth-hormone release. One time measures the drug; the other measures the gland's response. Ask what the doctor would test at return visits, because quick drug removal doesn't settle whether years of treatment would help you or cause later problems.

Why was a Sermorelin injection placed under skin or in a vein?
Most growth studies gave bedtime shots just beneath the skin. The gland normally releases growth hormone in bursts, often at night. Researchers used bedtime to increase the release that already happened then. That choice doesn't establish that you need the shot or choose a schedule for you.
The shots weren't alike in gland tests and growth studies.
Earlier work found that a constant drug supply gradually reduced growth-hormone release. Gaps between bedtime shots helped the gland keep responding over months [18]. Children's growth studies used separate nightly shots for that reason. Ask what the timing findings mean for the tests a doctor proposes.
Why did a Sermorelin gland test use a vein?
Growth studies used shots beneath the belly or thigh skin at bedtime [3][9]. Gland tests put 1 microgram for each kilogram of weight into a vein. Researchers could then measure the quick hormone response at a known time [6]. Those descriptions explain the tests, rather than tell you how to give yourself an injection.

What happened when Sermorelin was given without a break?
Early studies found that a constant supply reduced the gland's response within hours [18]. Leaving gaps allowed the gland to respond to separate shots. It's also at night that growth hormone normally comes in bursts. That explains why researchers chose gaps, rather than keeping drug in blood all day.
More time with drug in blood didn't always mean more growth hormone.
The same concern matters when discussing drugs the body takes longer to break down. Tesamorelin's approved daily treatment concerns excess fat far inside the belly in people with HIV. HIV, a virus, attacks the body's immune system. Researchers considered the gaps between shots alongside the normal rise and fall of growth hormone [13][18]. Ask whether the people receiving the drug gained the benefit you're seeking. Time in blood can't answer that.
In the 1980s, Vance found that separate treatments preserved hormone release better than a constant supply [18]. Later children's studies used bedtime shots in light of that work. Those study times can't prove that treatment now would improve your health. Ask about each return visit's cost, tests and purpose, and when care would be reviewed.
Some adult work tried morning shots or shots twice daily. Bedtime shots were more common. Khorram's 16-week study used nightly skin shots containing 10 micrograms for each kilogram of weight [9]. Vittone's healthy older men had a single nightly shot [10]. The 1980s work explains why leaving gaps mattered in research. Ask what a weaker gland response would mean for care. Timing can't prove benefits.